493 related articles for article (PubMed ID: 22085817)
21. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
22. The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan.
Huang MY; Chung CH; Chang WK; Lin CS; Chen KW; Hsieh TY; Chien WC; Lin HH
Am J Cancer Res; 2017; 7(7):1606-1616. PubMed ID: 28744408
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
Veldt BJ; Chen W; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; de Knegt RJ; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
Hepatology; 2008 Jun; 47(6):1856-62. PubMed ID: 18506898
[TBL] [Abstract][Full Text] [Related]
24. Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
Tung HD; Wang JH; Tseng PL; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen YD; Lu SN
Am J Gastroenterol; 2010 Mar; 105(3):624-31. PubMed ID: 20051944
[TBL] [Abstract][Full Text] [Related]
25. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin.
Hsu CC; Wahlqvist ML; Lee MS; Tsai HN
J Alzheimers Dis; 2011; 24(3):485-93. PubMed ID: 21297276
[TBL] [Abstract][Full Text] [Related]
26. Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan.
Ishiguro S; Inoue M; Tanaka Y; Mizokami M; Iwasaki M; Tsugane S;
Eur J Cancer Prev; 2009 Feb; 18(1):26-32. PubMed ID: 19077561
[TBL] [Abstract][Full Text] [Related]
27. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
28. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
29. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
[TBL] [Abstract][Full Text] [Related]
30. Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.
Hung CH; Lee CM; Wang JH; Hu TH; Chen CH; Lin CY; Lu SN
Int J Cancer; 2011 May; 128(10):2344-52. PubMed ID: 20669224
[TBL] [Abstract][Full Text] [Related]
31. Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II).
Inoue M; Kurahashi N; Iwasaki M; Tanaka Y; Mizokami M; Noda M; Tsugane S;
Cancer Causes Control; 2009 Jul; 20(5):741-50. PubMed ID: 19115074
[TBL] [Abstract][Full Text] [Related]
32. Editorial: hepatocellular carcinoma in type 2 diabetes: more than meets the eye.
Baffy G
Am J Gastroenterol; 2012 Jan; 107(1):53-5. PubMed ID: 22218030
[TBL] [Abstract][Full Text] [Related]
33. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
34. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
[TBL] [Abstract][Full Text] [Related]
35. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
37. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
Sacco M; Ribaldone DG; Saracco GM
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140692
[TBL] [Abstract][Full Text] [Related]
38. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
39. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]